a

 

Communicable Diseases Department

 

Profile and Vision

 

Organogram

 

Emerging diseases: preparedness and response

 

Surveillance and Response

 

   Avian Influenza

 

   Dengue Fever

 

   Chikungunya Fever

 

International Health Regulations

 

Laboratory support

 

Prevention & control of priority communicable diseases

 

HIV/AIDS    

 

Malaria

 

Tuberculosis

 

Transfusion transmitted infections

 

Elimination and eradication of communicable diseases

 

Leprosy

 

Lymphatic filariasis & Soil-transmitted Helminthiasis

 

Kala azar

 

Yaws

Communicable Diseases Department

About CDS

Issues and challenges

 

Burden of Communicable Diseases

According to WHO, infectious and parasitic diseases cause every year around  10.9 million deaths and result in a loss of an estimated 350 million DALYs. Of these about 56% deaths are caused by HIV/AIDS, TB and malaria (World Health Report 2004). In the countries of SEA Region, an estimated 2.62 million deaths are caused by infectious and parasitic diseases. In the Region an estimated 89 million DALYs are lost as a result of infectious diseases. The distribution of infectious diseases globally conforms to the distribution of poverty.

Each year, 250 000 children in the region die of measles and 750 000 adults of TB. More than 6.5 million people are living with HIV/AIDS and 250 million are at risk for malaria. In addition, epidemics of  infectious diseases occur frequently and in new areas; many of them are predictable but some of them take health system by surprise. SARS, avian influenza and Nipah virus are recent examples of such surprises and are capable of causing enormous socio-economic hardship across countries beyond national borders. Avian influenza is now anticipated to assume pandemic proportions and requires global comprehensive and multisectoral efforts to minimize its impact on human health and economy.

Other examples are Dengue/DHF and the new strain of cholera spreading to areas where these were not found earlier. Age-old diseases like leprosy and Kala-azar still cause considerable suffering and misery and psycho-social disruption, particularly in this region. Drug resistance is also a serious and an emerging threat.

Vulnerability of region

The Region has about 30% of the population living below an income of 1 USD per day. The interactions between infectious diseases, poverty and undernutrition are strong. This poses a special challenge to the effective control of infectious diseases in the Region. The countries in the region are faced with the burden of non communicable disease in addition to the infectious disease burden. This would place a heavy strain on the fragile and overstretched health system in the countries of the Region. Evidence is also linking to the occurrence of cancer and degenerative diseases to infectious diseases

The scenario of infectious diseases is shaped by many factors. There is a dramatic threat of resurgence of infectious diseases. This is attributable to the natural behaviour of the microbes which are complex and constantly evolving. They take advantage of every opportunity to multiply, mutate, migrate, adapt and become resistant to commonly used medicines and insecticides. H5N1 virus is the most striking and recent example of this behaviour.

During the last few decades, while the arsenal of antimicrobials is not expanding, the appearance and spread of antimicrobial resistance is closing down the limited number of windows available for the control of infectious diseases. The specter of emergence of drug resistance is threatening to undermine the gains achieved. The countries in the region are becoming the epicenter for antimalarial drug resistance with more than 30% of the population at risk. TB drug resistance is manifested by the hot spots. The resistance to chloramphenicol in enteric fever and to penicillin in gonococcal infection is a matter of concern. Treatment of drug resistant TB is more than 100 times the cost of DOTS medicines in the developing countries.

Success Stories

There is however many success stories too which indicate that if effective approaches are scaled up both in coverage and quality along with high level commitment and political will, we could overcome these problems. For example, Guineaworm disease and small pox have been eradicated from the countries in the Region. Polio is on the verge of eradication and leprosy elimination is on the horizon. Much progress has been made towards increasing the access to DOTS strategy and the achievement of targets in Lymphatic filariasis (LF) elimination programme is encouraging.

The political commitment made in recent years, the participation of academic institutions, networking, intercountry cooperation and planning are contributing to the success. The partnerships to tackle communicable diseases are expanding. This trend has to be sustained. The countries in the Region have been successful in mobilizing substantial funds from GFATM to be able to scale up their response to the control of HIV/AIDS, TB and Malaria.

Despite the bad news, there are many success stories indicating that despite the challenges, these problems can be overcome with sustained efforts. For example, guineaworm disease has been eradicated, polio is on the verge of eradication and leprosy elimination targets are likely to be achieved by the year 2005. Much progress has been made in the implementation of DOTS strategy for the control of TB and in mass drug treatment in elimination of lymphatic filariasis. With the support of WHO, the countries in the region have succeeded in mobilizing more than 1 billion US Dollars from GFATM for scaling up the control of HIV/AIDS, TB and malaria.

 

||| | ||